France· FR:69831794
LOPINAVIR/RITONAVIR VIATRIS 100 mg/25 mg, comprimé pelliculé
A lopinavir and ritonavir product containing lopinavir + ritonavir, registered in France by VIATRIS (IRLANDE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Lopinavir and ritonavir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AR10 (lopinavir and ritonavir), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Lopinavir and ritonavir · ATC J05AR10
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lopinavir and ritonavir costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $17.81 in Switzerland to $763.00 in France — a ×43 gap.
- France: $763.00 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Lopinavir and ritonavir · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- FR France$763.00
- CH Switzerland$17.81
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LOPINAVIR + RITONAVIR
- Manufacturer
- VIATRIS (IRLANDE)
- Country
- France (FR)
- ATC code
- J05AR10
- ATC class
- Lopinavir and ritonavir
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093006002560 plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)EUR 41.13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
136 interactions on record for lopinavir and ritonavir.
Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lopinavir and ritonavir · interactions on record
136 records
- 17 severe
- 71 moderate
- 7 minor
Most severe, free to view
- PapaverineA03AD01severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- RosuvastatinC10AA07severe
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lopinavir and ritonavir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKaletraAbbVie Inc.
- CzechiaKALETRAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandKaletraOrifarm Oy
- United KingdomKaletra 100mg/25mg tabletsAbbVie Ltd
- SpainKALETRA (80 MG + 20 MG)/ML SOLUCION ORALAbbvie Deutschland Gmbh & Co. Kg
- NetherlandsKaletra (80 mg + 20 mg) /ml drankAbbVie Deutschland GmbH & Co. KG
- IrelandKaletraAbbVie Deutschland GmbH & Co. KG
- IcelandKaletraAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Estonia · Lopinavir/Ritonavir Ranbaxy, Lopinavir/Ritonavir Sun
- Spain · Lopinavir / Ritonavir Accord
- United Kingdom (Northern Ireland) · Kaletra, Lopinavir / Ritonavir Accord
- Iceland · Kaletra, Lopinavir/Ritonavir Mylan
- Liechtenstein · Kaletra, Lopinavir/Ritonavir Viatris
- Lithuania · Lopinavir / Ritonavir Sun, Lopinavir /Ritonavir Ranbaxy
- Latvia · Lopinavir/ Ritonavir Ranbaxy, Lopinavir/ Ritonavir Sun
- Netherlands · Lopinavir/Ritonavir Accord
- Norway · Kaletra, Lopinavir/Ritonavir Viatris
- Portugal · Lopinavir + Ritonavir Farmoz
- Slovenia · Lopinavir/Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fed00942-951c-4a3e-aea2-bea5c37485a2 GET /v1/drugs/fed00942-951c-4a3e-aea2-bea5c37485a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69831794",
"date_amm": "2016-01-14",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1067",
"substance": "LOPINAVIR + RITONAVIR",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lopinavir and ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.